STKS Q1 2026 Earnings EPS Misses Estimates as Company Faces Operating Headwinds XPON Q2 2025 Earnings Strong EPS Beat Highlights Cost Discipline CLLS Q1 2026 Earnings Narrowed Loss Surprises Amid Clinical Focus CSV Q1 2026 Earnings Slight EPS Beat Amid Mixed Market Reaction Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings Narrower Net Loss Beats Estimates Amid Pipeline Progress OPRA Q1 2026 Earnings EPS Surpasses Estimates Stock Declines Modestly